Skip to main navigation Skip to search Skip to main content

Oral daily PTH(1-34) tablets (EB613) in postmenopausal women with low BMD or osteoporosis: a randomized, placebo-controlled, 6-month, phase 2 study

  • Liana Tripto-Shkolnik
  • , Auryan Szalat
  • , Gloria Tsvetov
  • , Vanessa Rouach
  • , Chana Sternberg
  • , Anke Hoppe
  • , Gregory Burshtein
  • , Hillel Galitzer
  • , Miranda Toledano
  • , Gil Harari
  • , Arthur C. Santora
  • , Felicia Cosman

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Oral daily PTH(1-34) tablets (EB613) in postmenopausal women with low BMD or osteoporosis: a randomized, placebo-controlled, 6-month, phase 2 study'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science